SART3 and neoplasm: They used a set of 11 single peptides to detect immune responses against the five tumor-associated antigens SART2, SART3, MRP3, AFP and hTERT and described an RFA-induced increase of IFN-y producing tumor-specific T cells for all of these peptides.